Tammer Bagdasarian

Stanford researchers conduct clinical trials for REGN-COV2, experimental drug given to Trump

Stanford researchers are conducting inpatient and outpatient clinical trials of Regeneron’s REGN-COV2, an experimental “antibody cocktail” administered to President Donald Trump after he tested positive for COVID-19. Some noted that many of the newest drugs Trump has access to are still being tested in clinical trials and are unavailable to most COVID-19 patients.
Load more